Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis

被引:182
作者
Lüttges, J
Galehdari, H
Bröcker, V
Schwarte-Waldhoff, I
Henne-Bruns, D
Klöppel, G
Schmiegel, W
Hahn, SA
机构
[1] Ruhr Univ Bochum, Dept Internal Med, D-44892 Bochum, Germany
[2] Univ Kiel, Dept Pathol, D-2300 Kiel, Germany
[3] Univ Kiel, Dept Surg, Kiel, Germany
关键词
D O I
10.1016/S0002-9440(10)64123-5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The presumed precursor lesions of pancreatic ductal adenocarcinoma were recently classified according to their increasing grade of dysplasia and were designated as pancreatic intraepithelial neoplasia (PanIN) 1 through 3, In this study, me tested whether molecular genetic alterations can be correlated with this classification and may help to further categorize the various PanIN grades. We determined the frequencies of allelic loss at chromosomal arms 9p, 17p, and 18q in 81 microdissected duct lesions of various PanIN grades, using a combination of whole genome amplification and microsatellite analysis. In addition we examined the p53 and Dpc4 protein expression patterns by immunohistochemical analysis. In PanLN-1, we did not detect allelic losses. In PanIN-2, allelic losses were found in increasing frequency, and were particularly high in those lesions with moderate-grade dysplasia (low grade, 20, 33, and 17%, loss at 9p, 17p, and 18q, respectively; moderate grade, 46, 77, and 58%), PanIN-3 and invasive carcinomas exhibited abundant losses. Abnormal p53 and Dpc4 protein expression was only rarely identified in PanIN-2 lesions, but occurred frequently in PanIN-3 lesions and invasive carcinomas, The combined genetic and protein expression data support a model in which allelic loss is the first hit in the biallelic inactivation of the p53 and DPC4 tumor suppressor genes, In addition, our data indicate that allelic loss analysis may be useful in separating PanIN-2 lesions with low-grade dysplasia from those PanIN-2 lesions with moderate-grade dysplasia, each potentially representing a distinct progression step toward invasive carcinoma.
引用
收藏
页码:1677 / 1683
页数:7
相关论文
共 25 条
[1]  
BOSCHMAN CR, 1994, AM J PATHOL, V145, P1291
[2]   Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA [J].
Cheung, VG ;
Nelson, SF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (25) :14676-14679
[3]  
CUBILLA AL, 1976, CANCER RES, V36, P2690
[4]   OVEREXPRESSION OF P53 PROTEIN IN ADENOCARCINOMA OF THE PANCREAS [J].
DIGIUSEPPE, JA ;
HRUBAN, RH ;
GOODMAN, SN ;
POLAK, M ;
VANDENBERG, FM ;
ALLISON, DC ;
CAMERON, JL ;
OFFERHAUS, GJA .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1994, 101 (06) :684-688
[5]  
Fukushige S, 1998, CANCER RES, V58, P4222
[6]   DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 [J].
Hahn, SA ;
Schutte, M ;
Hoque, ATMS ;
Moskaluk, CA ;
daCosta, LT ;
Rozenblum, E ;
Weinstein, CL ;
Fischer, A ;
Yeo, CJ ;
Hruban, RH ;
Kern, SE .
SCIENCE, 1996, 271 (5247) :350-353
[7]   Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma [J].
Heinmöller, E ;
Dietmaier, W ;
Zirngibl, H ;
Heinmöller, P ;
Scaringe, W ;
Jauch, KW ;
Hofstädter, F ;
Rüschoff, J .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (01) :83-92
[8]   Genetic progression in the pancreatic ducts - Commentary [J].
Hruban, RH ;
Wilentz, RE ;
Kern, SE .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (06) :1821-1825
[9]  
HRUBAN RH, IN PRESS AM J SURG P
[10]  
KALTHOFF H, 1993, ONCOGENE, V8, P289